Similar to the observations made for GOF SAMD9L mutations in ATXPC, GOF SAMD9 mutations were also reverted by other genetic mechanisms such as frame-shift or stop gain mutations in the blood of four individuals with MIRAGE syndrome (Fig. 3), including patients with non-manifest hematopoietic phenotype [28]. The gene discussed is SAMD9L; the disease is MIRAGE syndrome.